- Home
- DRVN vs VERA Comparison
DRVN vs VERA Comparison
Compare DRVN & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRVN
- VERA
- Stock Information
- Founded
- DRVN 1972
- VERA 2016
- Country
- DRVN United States
- VERA United States
- Employees
- DRVN N/A
- VERA N/A
- Industry
- DRVN Automotive Aftermarket
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- DRVN Consumer Discretionary
- VERA Health Care
- Exchange
- DRVN Nasdaq
- VERA Nasdaq
- Market Cap
- DRVN 2.7B
- VERA 2.8B
- IPO Year
- DRVN 2021
- VERA 2021
- Fundamental
- Price
- DRVN $16.10
- VERA $47.03
- Analyst Decision
- DRVN Buy
- VERA Strong Buy
- Analyst Count
- DRVN 12
- VERA 9
- Target Price
- DRVN $17.88
- VERA $54.33
- AVG Volume (30 Days)
- DRVN 702.0K
- VERA 1.2M
- Earning Date
- DRVN 10-31-2024
- VERA 11-07-2024
- Dividend Yield
- DRVN N/A
- VERA N/A
- EPS Growth
- DRVN N/A
- VERA N/A
- EPS
- DRVN 0.03
- VERA N/A
- Revenue
- DRVN $2,329,148,000.00
- VERA N/A
- Revenue This Year
- DRVN $4.04
- VERA N/A
- Revenue Next Year
- DRVN $7.93
- VERA N/A
- P/E Ratio
- DRVN $539.81
- VERA N/A
- Revenue Growth
- DRVN 1.71
- VERA N/A
- 52 Week Low
- DRVN $10.59
- VERA $12.28
- 52 Week High
- DRVN $16.93
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- DRVN 57.69
- VERA 55.84
- Support Level
- DRVN $16.41
- VERA $43.41
- Resistance Level
- DRVN $16.79
- VERA $46.82
- Average True Range (ATR)
- DRVN 0.42
- VERA 2.61
- MACD
- DRVN -0.04
- VERA -0.27
- Stochastic Oscillator
- DRVN 61.75
- VERA 47.27
About DRVN Driven Brands Holdings Inc.
Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.